Bullish & Foolish
Full FEED fundamentals All 466 on the Survival Watch

FEEDENvue Medical, Inc.

Is ENvue Medical struggling financially?

Yes, by its own account. ENvue Medical told the SEC on 18 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Sector
Biotech/Pharma
Market cap
$4.3M
Source filing
10-Q 18 May 2026
Balance sheet
31 Mar 2026

Cash runway

1–2 mo

Runs out some time after May 2026, raising nothing.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$2.2M

÷

Cash burned over the last 12 months

$18.5M

What ENvue Medical told the SEC

…however, that the Company will be able to obtain an adequate level of financial resources that are required to fund its operation. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for twelve months from the date of issuance of these interim condensed consolidated financial statements. The accompanying interim condensed consolidated financial statements do not…

ENvue Medical, Inc., Form 10-Q, filed 18 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 425.3% share-count increase The company issued stock. Each share now owns 81.0% less of the business than a year ago, before any change in the price.
  • Cash burn is increasing It is spending 270% more cash per year than it was, so the runway above shortens even if nothing else changes.

Other Biotech/Pharma companies that filed the doubt